Curative Biotechnology Inc (CUBT) — Cash Flow Quality Index
Curative Biotechnology Inc (CUBT) has a Cash Flow Quality Index of -0.04x as of March 2020. Operating cash flow of $-14.53K is below net income of $363.64K, suggesting accrual-heavy earnings not yet converted to cash. Explore Curative Biotechnology Inc (CUBT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Curative Biotechnology Inc Cash Flow Quality Index (2015–2019)
Historical Cash Flow Quality Index for Curative Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Curative Biotechnology Inc cash conversion from operations.
Annual Cash Flow Quality Index for Curative Biotechnology Inc (2015–2019)
Year-by-year earnings quality comparison for Curative Biotechnology Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $-150.00 | $331.95K | ▼ -104.4% |
| 2015 | 0.01x | $1.96K | $190.84K | — |